Myomo (MYO) Share-based Compensation (2016 - 2025)
Myomo's (MYO) quarterly Share-based Compensation came in at $4.6 million in Q3 2025, up 1304.78% YoY from $324185.0 in Q3 2024, and up 1053.26% on a QoQ basis from $394889.0 in Q2 2025.
Myomo (MYO) Share-based Compensation (2016 - 2025) Analysis & Trends
Myomo (MYO) has 10 years of Share-based Compensation data on file, last reported at $4.6 million in Q3 2025.
- Quarterly Share-based Compensation rose 1304.78% year-over-year to $4.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $4.6 million (up 413.62% YoY) and the FY2024 annual result came in at $7.5 million, up 571.58% from the prior year.
- Share-based Compensation climbed to $4.6 million in Q3 2025, from $394889.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $6.9 million in Q4 2024 to a low of -$91893.0 in Q2 2024.
- A 5-year average of $862307.2 and a median of $320288.0 in 2024 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 1977.17% in 2024, down 132.81% in 2024.
- Tracing MYO's Share-based Compensation over 5 years: stood at $265362.0 in 2021, then gained by 3.02% to $273368.0 in 2022, then increased by 22.21% to $334089.0 in 2023, then surged by 1977.17% to $6.9 million in 2024, then sank by 34.38% to $4.6 million in 2025.
- The last three Share-based Compensation figures came in at $4.6 million (Q3 2025), $394889.0 (Q2 2025), and $540204.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Myomo | 72.11 Mn | 53.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.55 Mn |
| Sep 30, 2025 | 4.55 Mn |
| Jun 30, 2025 | 394,889.00 |
| Jun 30, 2025 | 394,889.00 |
| Mar 31, 2025 | 540,204.00 |
| Mar 31, 2025 | 540,204.00 |
| Dec 31, 2024 | 6.94 Mn |
| Dec 31, 2024 | 6.94 Mn |
| Sep 30, 2024 | 324,185.00 |
| Sep 30, 2024 | 324,185.00 |
| Jun 30, 2024 | -91,893.00 |
| Jun 30, 2024 | -91,893.00 |
| Mar 31, 2024 | 320,288.00 |
| Mar 31, 2024 | 320,288.00 |
| Dec 31, 2023 | 334,089.00 |
| Dec 31, 2023 | 334,089.00 |
| Sep 30, 2023 | 330,394.00 |
| Sep 30, 2023 | 330,394.00 |
| Jun 30, 2023 | 280,061.00 |
| Jun 30, 2023 | 280,061.00 |